share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/12/23 16:33

Moomoo AI 已提取核心信息

FOXO Technologies announced it will hold its 2024 Annual General Meeting virtually on December 31, 2024, at 9:30 am CST. Shareholders of record as of December 19, 2024, will be eligible to vote on proposals including director appointments and auditor approval through a live webcast platform.CEO Seamus Lagan highlighted 2024 as a transformative year for FOXO, noting the company has resolved all NYSE American listing deficiencies and completed significant revenue-generating acquisitions. The company operates through three subsidiaries: Foxo Labs Inc. (biotechnology), Myrtle Recovery Centers Inc. (behavioral health facility), and Rennova Community Health Inc. (critical access hospital).Management indicated that a separate Special Meeting will be scheduled soon to address additional matters requiring shareholder approval. The company expressed optimism about its acquisition and growth strategy driving significant value creation in 2025 and beyond.
FOXO Technologies announced it will hold its 2024 Annual General Meeting virtually on December 31, 2024, at 9:30 am CST. Shareholders of record as of December 19, 2024, will be eligible to vote on proposals including director appointments and auditor approval through a live webcast platform.CEO Seamus Lagan highlighted 2024 as a transformative year for FOXO, noting the company has resolved all NYSE American listing deficiencies and completed significant revenue-generating acquisitions. The company operates through three subsidiaries: Foxo Labs Inc. (biotechnology), Myrtle Recovery Centers Inc. (behavioral health facility), and Rennova Community Health Inc. (critical access hospital).Management indicated that a separate Special Meeting will be scheduled soon to address additional matters requiring shareholder approval. The company expressed optimism about its acquisition and growth strategy driving significant value creation in 2025 and beyond.
FOXO科技公司宣布将于2024年12月31日上午9:30(中部时间)在线召开2024年年度股东大会。截止到2024年12月19日的股东将能够通过直播平台投票,参与包括董事任命和审计师批准在内的提案。首席执行官Seamus Lagan强调2024年是FOXO的一个变革性年,指出公司已解决所有纽交所美国上市缺陷并完成了显著的营业收入生成收购。该公司通过三家子公司运营:Foxo Labs Inc.(生物技术)、Myrtle Recovery Centers Inc.(行为健康设施)和Rennova社区健康公司(关键接入医院)。管理层表示,另行定期召开的特别会议将很快安排,以处理需要股东批准的其他事项。公司对其收购和增长策略抱有乐观态度,认为这将推动2025年及以后的重大价值创造。
FOXO科技公司宣布将于2024年12月31日上午9:30(中部时间)在线召开2024年年度股东大会。截止到2024年12月19日的股东将能够通过直播平台投票,参与包括董事任命和审计师批准在内的提案。首席执行官Seamus Lagan强调2024年是FOXO的一个变革性年,指出公司已解决所有纽交所美国上市缺陷并完成了显著的营业收入生成收购。该公司通过三家子公司运营:Foxo Labs Inc.(生物技术)、Myrtle Recovery Centers Inc.(行为健康设施)和Rennova社区健康公司(关键接入医院)。管理层表示,另行定期召开的特别会议将很快安排,以处理需要股东批准的其他事项。公司对其收购和增长策略抱有乐观态度,认为这将推动2025年及以后的重大价值创造。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息